Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Artificial intelligence-driven personalized dietary recommendations for gastric cancer high-risk populations: a
Jiahao Chen1, Tianyuan Sun1, Jiayi Zhang1
1Department of Gastrointestinal Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
Abstract:
This review summarizes the current applications of artificial intelligence (AI) in providing personalized dietary recommendations, and explores its potential applicability to populations at high risk for gastric cancer. Currently, there are no direct intervention trials for gastric cancer patients. However, evidence from metabolic diseases (like diabetes and obesity) shows that AI-driven dietary interventions could be beneficial. This approach may offer translatable benefits for cancer prevention. First, the paper elaborates on the severe incidence of gastric cancer and the limitations of traditional preventive measures, emphasizing the necessity of developing precise and efficient intervention strategies. Subsequently, it systematically outlines methods for identifying high-risk populations and risk stratification (including pathological basis, biomarkers, and genetic risks), as well as the close relationship between dietary patterns (protective and risky) and gastric cancer risk, with a particular focus on the interaction between diet and the gastric microbiome (especially Helicobacter pylori). The core section analyzes the technical principles of AI-driven personalized nutritional interventions (such as machine learning and deep learning) and their practical effects in improving chronic diseases like blood glucose control and obesity management, while looking forward to the potential of integrating AI with multi-omics data. In addition, the paper extends the discussion to the extended applications of AI in improving screening adherence, assisting endoscopic diagnosis, and clinical decision support systems. Finally, the paper points out current challenges such as technical interpretability, data privacy, population differences, and clinical validation, and proposes prospects for future research directions.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Cancer Prevention
Targeted Cancer Therapies
There are several types of targeted therapies against...
What is Monogastric Digestion?
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
